SOE Minister Praises Bio Farma's Strategic Impact on Global Health Sustainability

^{Image: Minister of State-Owned Enterprises (SOEs) Erick Thohir, Special Staff III of the Ministry of SOEs Arya Sinulingga, and Bio Farma Deputy Director Soleh Ayubi (right) participated in a press conference at the Ministry of SOEs in Jakarta.}

Indonesia's Minister of State-Owned Enterprises (SOEs), Erick Thohir, has commended Bio Farma for its growing influence on the global health stage. The company has not only expanded its vaccine production capacity but has also reaffirmed its dedication to advancing humanitarian welfare worldwide.

“Bio Farma’s contributions transcend medical solutions,” said Mr. Thohir at a press briefing in Jakarta on Friday. “They also play a vital role in promoting peace and stability in vulnerable regions.”

Bio Farma’s reputation as a cornerstone of global health efforts is reflected in its ability to supply vaccines to 700 million children in 153 countries. This achievement underscores the company’s strategic commitment to positioning Indonesia as a major force in the global health supply chain.

Mr. Thohir also highlighted Bio Farma’s efforts in aiding Indonesia’s recovery from the pandemic, citing the development of a vaccine tailored specifically for the Indonesian population.

Deputy Director Soleh Ayubi, who accompanied the Minister, revealed that Bio Farma represented Indonesia at the Annual General Meeting of the Developing Countries Vaccine Manufacturers Network (DCVMN) in São Paulo, Brazil, in October 2024. The company has also been chosen to host the prestigious event in 2025, further cementing its global standing.

The increasing global demand for vaccines presents Bio Farma with an opportunity to enhance its production capabilities. Plans are underway to scale up manufacturing capacity from 3.1 billion doses annually to nearly five times that amount through the establishment of a cutting-edge facility. This initiative positions Bio Farma as a frontrunner in the international vaccine market.

In the last two years, Bio Farma’s export revenue has soared by 80%, demonstrating its growing influence. By ensuring vaccine access for underserved communities, the company continues to play a critical role in addressing global health disparities.

"Bio Farma has established itself as a reliable hub for vaccine production," said Mr. Ayubi. "By ensuring a seamless supply chain, the company meets the demands of its expansive international network, reaffirming its commitment to global health."

A recent example of Bio Farma’s humanitarian impact took place in Gaza, where a three-day ceasefire was brokered to allow polio vaccinations for Palestinian children, facilitated using Bio Farma’s vaccines.

Commitment to Sustainability

Bio Farma is also advancing sustainability through a "traceback" system, which tracks each vaccine batch and records the energy used during production. This innovation is key for meeting the requirements for UNICEF's 2026 tender.

“Bio Farma’s focus on green energy and environmental responsibility strengthens its leadership in sustainable healthcare practices,” Mr. Ayubi remarked.

With its strategic roadmap and unwavering dedication, Bio Farma continues to shape its role as a global health leader, ensuring both equitable healthcare access and long-term sustainability.